tiprankstipranks
Advertisement
Advertisement
ARS reports no new commercial formulary additions, coverage decisions for neffy
PremiumThe FlyARS reports no new commercial formulary additions, coverage decisions for neffy
27d ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
1M ago
Analyst Maintains Buy on ARS Pharmaceuticals as Neffy Access Prospects and Commercial Execution Improve
Premium
Ratings
Analyst Maintains Buy on ARS Pharmaceuticals as Neffy Access Prospects and Commercial Execution Improve
2M ago
Morning Movers: Cerebras Systems pulls back after smash IPO
PremiumThe FlyMorning Movers: Cerebras Systems pulls back after smash IPO
2M ago
Options Volatility and Implied Earnings Moves Today, May 15, 2026
Premium
Market News
Options Volatility and Implied Earnings Moves Today, May 15, 2026
2M ago
ARS Pharmaceuticals Highlights Strong Neffy Growth and Global Expansion
Premium
Company Announcements
ARS Pharmaceuticals Highlights Strong Neffy Growth and Global Expansion
2M ago
Northland starts disruptor ARS Pharmaceuticals with an Outperform
PremiumThe FlyNorthland starts disruptor ARS Pharmaceuticals with an Outperform
3M ago
Ars Pharmaceuticals Earnings Call Highlights Neffy’s Early Traction
Premium
Company Announcements
Ars Pharmaceuticals Earnings Call Highlights Neffy’s Early Traction
4M ago
ARS Pharmaceuticals receives FDA approval to remove neffy 1 mg age requirement
Premium
The Fly
ARS Pharmaceuticals receives FDA approval to remove neffy 1 mg age requirement
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100